SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 20th, 2021 • Akari Therapeutics PLC • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 6, 2021, between Akari Therapeutics, PLC, a public company with limited liability incorporated under the laws of England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
